Arvinas Gross Profit Margin vs Asset Turnover Analysis

ARVN Stock

USD 18.05 0.47 2.67%

Arvinas financial indicator trend analysis is way more than just evaluating Arvinas prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arvinas is a good investment. Please check the relationship between Arvinas Gross Profit Margin and its Asset Turnover accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.

Gross Profit Margin vs Asset Turnover

Gross Profit Margin vs Asset Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arvinas Gross Profit Margin account and Asset Turnover. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Arvinas' Gross Profit Margin and Asset Turnover is -0.01. Overlapping area represents the amount of variation of Gross Profit Margin that can explain the historical movement of Asset Turnover in the same time period over historical financial statements of Arvinas, assuming nothing else is changed. The correlation between historical values of Arvinas' Gross Profit Margin and Asset Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit Margin of Arvinas are associated (or correlated) with its Asset Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Asset Turnover has no effect on the direction of Gross Profit Margin i.e., Arvinas' Gross Profit Margin and Asset Turnover go up and down completely randomly.

Correlation Coefficient

-0.01

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Gross Profit Margin

Asset Turnover

The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.

Most indicators from Arvinas' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arvinas current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.At this time, Arvinas' Tax Provision is very stable compared to the past year. As of the 18th of January 2025, Selling General Administrative is likely to grow to about 121.1 M, while Issuance Of Capital Stock is likely to drop about 31.7 M.

	2022	2023	2024	2025 (projected)
Interest Income	12.2M	32.3M	37.1M	39.0M
Net Interest Income	12.2M	32.3M	37.1M	39.0M

Interest Income Net Interest Income

Arvinas fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity
Total Assets		0.84	0.79	0.92	0.97	0.92	0.95	0.94	0.92	-0.58	-0.89	0.86	0.6	0.99	0.82	0.35	0.36	0.95	0.45	-0.76	0.95	0.96	0.42	0.92	0.91	0.89
Short Long Term Debt Total	0.84		0.66	0.75	0.87	0.73	0.91	0.96	0.77	-0.53	-0.77	0.67	0.54	0.9	0.6	0.46	0.72	0.82	0.35	-0.92	0.82	0.8	0.74	0.74	0.86	0.79
Other Current Liab	0.79	0.66		0.9	0.8	0.83	0.75	0.78	0.84	-0.71	-0.95	0.7	0.78	0.8	0.88	0.26	0.33	0.89	0.2	-0.68	0.85	0.7	0.41	0.82	0.65	0.96
Total Current Liabilities	0.92	0.75	0.9		0.84	0.98	0.81	0.84	0.99	-0.47	-0.94	0.84	0.55	0.92	0.97	0.4	0.25	0.97	0.44	-0.68	0.89	0.92	0.31	0.98	0.88	0.94
Total Stockholder Equity	0.97	0.87	0.8	0.84		0.83	0.99	0.96	0.84	-0.73	-0.87	0.84	0.74	0.96	0.72	0.26	0.5	0.92	0.37	-0.82	0.94	0.87	0.56	0.84	0.84	0.89
Other Liab	0.92	0.73	0.83	0.98	0.83		0.81	0.81	0.99	-0.41	-0.9	0.9	0.49	0.9	0.95	0.31	0.22	0.97	0.54	-0.66	0.86	0.94	0.28	1.0	0.88	0.91
Net Tangible Assets	0.95	0.91	0.75	0.81	0.99	0.81		0.97	0.82	-0.71	-0.84	0.81	0.72	0.95	0.67	0.29	0.56	0.9	0.37	-0.85	0.91	0.86	0.61	0.81	0.86	0.86
Property Plant And Equipment Net	0.94	0.96	0.78	0.84	0.96	0.81	0.97		0.84	-0.65	-0.87	0.75	0.67	0.97	0.71	0.41	0.59	0.9	0.37	-0.87	0.94	0.87	0.63	0.82	0.88	0.88
Current Deferred Revenue	0.92	0.77	0.84	0.99	0.84	0.99	0.82	0.84		-0.41	-0.9	0.84	0.48	0.92	0.96	0.45	0.23	0.96	0.48	-0.67	0.87	0.94	0.28	0.99	0.92	0.91
Net Debt	-0.58	-0.53	-0.71	-0.47	-0.73	-0.41	-0.71	-0.65	-0.41		0.63	-0.49	-0.99	-0.55	-0.35	0.05	-0.48	-0.61	-0.04	0.58	-0.63	-0.34	-0.53	-0.41	-0.35	-0.68
Retained Earnings	-0.89	-0.77	-0.95	-0.94	-0.87	-0.9	-0.84	-0.87	-0.9	0.63		-0.78	-0.69	-0.9	-0.9	-0.3	-0.42	-0.94	-0.3	0.8	-0.9	-0.84	-0.49	-0.89	-0.77	-0.98
Accounts Payable	0.86	0.67	0.7	0.84	0.84	0.9	0.81	0.75	0.84	-0.49	-0.78		0.55	0.82	0.77	-0.05	0.29	0.91	0.55	-0.65	0.77	0.84	0.34	0.9	0.73	0.84
Cash	0.6	0.54	0.78	0.55	0.74	0.49	0.72	0.67	0.48	-0.99	-0.69	0.55		0.58	0.45	-0.06	0.48	0.67	0.06	-0.61	0.66	0.37	0.53	0.48	0.37	0.75
Non Current Assets Total	0.99	0.9	0.8	0.92	0.96	0.9	0.95	0.97	0.92	-0.55	-0.9	0.82	0.58		0.82	0.43	0.41	0.94	0.43	-0.79	0.96	0.96	0.47	0.91	0.93	0.89
Non Currrent Assets Other	0.82	0.6	0.88	0.97	0.72	0.95	0.67	0.71	0.96	-0.35	-0.9	0.77	0.45	0.82		0.38	0.09	0.9	0.37	-0.56	0.81	0.85	0.16	0.94	0.78	0.89
Other Assets	0.35	0.46	0.26	0.4	0.26	0.31	0.29	0.41	0.45	0.05	-0.3	-0.05	-0.06	0.43	0.38		0.07	0.29	0.04	-0.24	0.35	0.42	0.05	0.33	0.63	0.23
Long Term Debt	0.36	0.72	0.33	0.25	0.5	0.22	0.56	0.59	0.23	-0.48	-0.42	0.29	0.48	0.41	0.09	0.07		0.38	0.03	-0.86	0.31	0.26	0.99	0.22	0.31	0.46
Cash And Short Term Investments	0.95	0.82	0.89	0.97	0.92	0.97	0.9	0.9	0.96	-0.61	-0.94	0.91	0.67	0.94	0.9	0.29	0.38		0.45	-0.77	0.91	0.91	0.44	0.97	0.87	0.97
Net Receivables	0.45	0.35	0.2	0.44	0.37	0.54	0.37	0.37	0.48	-0.04	-0.3	0.55	0.06	0.43	0.37	0.04	0.03	0.45		-0.18	0.36	0.51	0.04	0.55	0.48	0.34
Common Stock Total Equity	-0.76	-0.92	-0.68	-0.68	-0.82	-0.66	-0.85	-0.87	-0.67	0.58	0.8	-0.65	-0.61	-0.79	-0.56	-0.24	-0.86	-0.77	-0.18		-0.7	-0.69	-0.89	-0.66	-0.69	-0.81
Common Stock Shares Outstanding	0.95	0.82	0.85	0.89	0.94	0.86	0.91	0.94	0.87	-0.63	-0.9	0.77	0.66	0.96	0.81	0.35	0.31	0.91	0.36	-0.7		0.89	0.38	0.86	0.84	0.89
Short Term Investments	0.96	0.8	0.7	0.92	0.87	0.94	0.86	0.87	0.94	-0.34	-0.84	0.84	0.37	0.96	0.85	0.42	0.26	0.91	0.51	-0.69	0.89		0.31	0.95	0.95	0.82
Long Term Debt Total	0.42	0.74	0.41	0.31	0.56	0.28	0.61	0.63	0.28	-0.53	-0.49	0.34	0.53	0.47	0.16	0.05	0.99	0.44	0.04	-0.89	0.38	0.31		0.28	0.34	0.53
Non Current Liabilities Total	0.92	0.74	0.82	0.98	0.84	1.0	0.81	0.82	0.99	-0.41	-0.89	0.9	0.48	0.91	0.94	0.33	0.22	0.97	0.55	-0.66	0.86	0.95	0.28		0.89	0.91
Other Current Assets	0.91	0.86	0.65	0.88	0.84	0.88	0.86	0.88	0.92	-0.35	-0.77	0.73	0.37	0.93	0.78	0.63	0.31	0.87	0.48	-0.69	0.84	0.95	0.34	0.89		0.76
Other Stockholder Equity	0.89	0.79	0.96	0.94	0.89	0.91	0.86	0.88	0.91	-0.68	-0.98	0.84	0.75	0.89	0.89	0.23	0.46	0.97	0.34	-0.81	0.89	0.82	0.53	0.91	0.76

Click cells to compare fundamentals

Arvinas Account Relationship Matchups

Arvinas fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	717.4M	1.6B	1.3B	1.3B	1.5B	753.2M
Short Long Term Debt Total	4.0M	5M	5.5M	3.2M	3.7M	3.4M
Other Current Liab	41.0M	22M	56.9M	73.7M	84.8M	89.0M
Total Current Liabilities	49.1M	261.7M	295.1M	257.1M	295.7M	310.4M
Total Stockholder Equity	642.3M	781.7M	564.9M	660M	759M	417.5M
Other Liab	38.4M	22.9M	534.3M	405.1M	465.9M	489.2M
Net Tangible Assets	226.7M	642.3M	781.7M	564.9M	649.6M	354.8M
Property Plant And Equipment Net	14.3M	16.6M	17.8M	14M	16.1M	10.8M
Current Deferred Revenue	22.2M	206.2M	218.6M	163M	187.5M	196.8M
Net Debt	(584.3M)	(103.3M)	(75.8M)	(308.5M)	(277.7M)	(263.8M)
Retained Earnings	(491.9M)	(682.9M)	(965.4M)	(1.3B)	(1.2B)	(1.1B)
Accounts Payable	7.1M	31.3M	5.7M	17.8M	20.5M	21.5M
Cash	588.4M	108.3M	81.3M	311.7M	358.5M	376.4M
Non Current Assets Total	14.3M	29.1M	28.6M	24.4M	28.1M	15.5M
Non Currrent Assets Other	(2.4M)	7.5M	10.8M	10.4M	12.0M	12.6M
Other Assets	28.8K	100K	10.8M	1.0	1.15	1.09
Cash And Short Term Investments	688.5M	1.5B	1.2B	1.3B	1.5B	1.5B
Net Receivables	1M	25.7M	8M	7.2M	8.3M	11.1M
Common Stock Total Equity	31.2K	38.5K	48.5K	100K	90K	85.5K
Common Stock Shares Outstanding	39.5M	50M	53.2M	55.5M	63.8M	38.4M
Short Term Investments	100.2M	1.4B	1.1B	949.3M	1.1B	558.6M
Liabilities And Stockholders Equity	717.4M	1.6B	1.3B	1.3B	1.5B	753.2M
Non Current Liabilities Total	26.0M	538.2M	408.8M	387.5M	445.6M	467.9M
Other Current Assets	6.1M	24.2M	26.9M	12M	13.8M	10.5M
Other Stockholder Equity	1.1B	1.5B	1.5B	2.0B	2.3B	2.4B
Total Liab	75.1M	799.9M	703.9M	644.6M	741.3M	778.4M
Property Plant And Equipment Gross	14.3M	16.6M	17.8M	35.1M	40.4M	42.4M
Total Current Assets	703.1M	1.6B	1.2B	1.3B	1.5B	737.7M
Accumulated Other Comprehensive Income	560.8K	(4.6M)	(19.2M)	(3.1M)	(2.8M)	(2.9M)
Non Current Liabilities Other	40.1M	24.0M	537.2M	407.8M	469.0M	492.4M
Short Term Debt	1M	2.2M	3.6M	1.9M	2.2M	1.4M
Common Stock	31.2K	38.5K	48.5K	100K	90K	85.5K
Property Plant Equipment	10.7M	12.3M	16.6M	13.4M	15.4M	9.2M
Net Invested Capital	644.3M	782.7M	565.9M	660.8M	759.9M	465.2M
Net Working Capital	654.0M	1.3B	945.1M	1.0B	1.2B	690.1M
Retained Earnings Total Equity	(372.6M)	(491.9M)	(682.9M)	(965.4M)	(868.9M)	(912.3M)
Capital Surpluse	599.1M	1.1B	1.5B	1.5B	1.8B	1.1B

Pair Trading with Arvinas

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arvinas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will appreciate offsetting losses from the drop in the long position's value.

Moving together with Arvinas Stock

0.65	ME	23Andme Holding	Pair Corr
0.64	VALN	Valneva SE ADR	Pair Corr

Moving against Arvinas Stock

0.83	CDIOW	Cardio Diagnostics	Pair Corr
0.82	DRTS	Alpha Tau Medical	Pair Corr
0.72	SRZNW	Surrozen Warrant	Pair Corr
0.66	DYAI	Dyadic International	Pair Corr
0.65	DMAC	DiaMedica Therapeutics	Pair Corr

The ability to find closely correlated positions to Arvinas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arvinas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arvinas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arvinas to buy it.

The correlation of Arvinas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Arvinas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock:

How To Invest In Arvinas

Details

Is Arvinas Stock a good investment?

Details

What is Arvinas' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.79)

Revenue Per Share

2.327

Quarterly Revenue Growth

1.96

Return On Assets

(0.20)

Return On Equity

(0.59)

The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Arvinas Gross Profit Margin vs Asset Turnover Analysis

Gross Profit Margin vs Asset Turnover

Gross Profit Margin vs Asset Turnover Correlation Analysis

Correlation Coefficient

Gross Profit Margin

Asset Turnover

Arvinas fundamental ratios Correlations

Arvinas Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Arvinas fundamental ratios Accounts

Pair Trading with Arvinas

Moving together with Arvinas Stock

Moving against Arvinas Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Other Liab
Non Current Assets Total	+ 0.99	Total Assets
Current Deferred Revenue	+ 0.99	Total Current Liabilities
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Current Deferred Revenue	+ 0.99	Other Liab
Non Current Liabilities Total	+ 0.99	Current Deferred Revenue

Cash	- 0.99	Net Debt
Other Stockholder Equity	- 0.98	Retained Earnings
Retained Earnings	- 0.95	Other Current Liab
Cash And Short Term Investments	- 0.94	Retained Earnings
Retained Earnings	- 0.94	Total Current Liabilities
Common Stock Total Equity	- 0.92	Short Long Term Debt Total